RSRonnett Seldon

Ronnett Seldon

*This is an algorithmically generated author record based on publicly available information.

Ronnett Seldon has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Digby Francis Warner

    Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa

    6 shared publications
  • Anastasia Koch

    Universiteit van Kaapstad

    2 shared publications
  • Audrey Jordaan

    Molecular Mycobacteriology Research Unit Department of Pathology and Institute of Infectious Disease and Molecular Medicine University of Cape Town Cape Town South Africa

    2 shared publications
  • Andiswa Vazi

    Aerobiology and TB Research Unit, Desmond Tutu Health Foundation

    1 shared publication
  • Andrea McKerry

    Aerobiology and TB Research Unit, Desmond Tutu Health Foundation

    1 shared publication
  • Audrey Jordaan

    SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Department of Pathology, and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa

    1 shared publication

Latest Publications

  • Open Access

    Persistent Mycobacterium tuberculosis bioaerosol release in a tuberculosis-endemic setting

    by Ryan Dinkele, Sophia Gessner, Benjamin Patterson, Andrea McKerry, Zeenat Hoosen, Andiswa Vazi, Ronnett Seldon, Anastasia Koch, Digby F. Warner, Robin Wood

    Pioneering studies linking symptomatic disease and cough-mediated release of Mycobacterium tuberculosis ( Mtb ) established the infectious origin of tuberculosis (TB), simultaneously informing the pervasive notion that pathology is a prerequisite for Mtb transmission. Our prior work has challenged this assumption: by sampling TB clinic attendees, we detected equivalent release of Mtb -containing bioaerosols by confirmed TB patients and individuals not receiving a TB diagnosis, and we demonstrated a time-dependent reduction in Mtb bioaerosol positivity during six-months’ follow-up, irrespective of anti-TB chemotherapy. Now, by extending bioaerosol sampling to a randomly selected community cohort, we show that Mtb release is common in a TB-endemic setting: of 89 participants, 79.8% (71/89) produced Mtb bioaerosols independently of QuantiFERON-TB Gold status, a standard test for Mtb infection; moreover, during two-months’ longitudinal sampling, only 2% (1/50) were serially Mtb bioaerosol negative. These results necessitate a reframing of the prevailing paradigm of Mtb transmission and infection, and may explain the current inability to elucidate Mtb transmission networks in TB-endemic regions. Summary: Elucidating chains of Mycobacterium tuberculosis transmission is limited by a dependence on linking sputum-positive tuberculosis cases. Here, we report persistent M. tuberculosis bioaerosol release in the majority of a randomly selected community cohort. The contribution to tuberculosis transmission is unknown.


  • Open Access

    Environmental air sampling for detection and quantification of Mycobacterium tuberculosis in clinical settings: Proof of concept

    by Keren Middelkoop, Anastasia S. Koch, Zeenat Hoosen, Wayne Bryden, Charles Call, Ronnett Seldon, Digby F. Warner, Robin Wood, Jason R. Andrews

    Objective:Novel approaches are needed to understand and disrupt Mycobacterium tuberculosis transmission. In this proof-of-concept study, we investigated the use of environmental air samplings to detect and quantify M. tuberculosis in different clinic settings in a high-burden area.Design:Cross-sectional, environmental sampling.Setting:Primary-care clinic.Methods:A portable, high-flow dry filter unit (DFU) was used to draw air through polyester felt filters for 2 hours. Samples were collected in the waiting area and TB room of a primary care clinic. Controls included sterile filters placed directly into collection tubes at the DFU sampling site, and filter samplings performed outdoors. DNA was extracted from the filters, and droplet digital polymerase chain reaction (ddPCR) was used to quantify M. tuberculosis DNA copies. Carbon dioxide (CO2) data loggers captured CO2 concentrations in the sampled areas.Results:The median sampling time was 123 minutes (interquartile range [IQR], 121–126). A median of 121 (IQR, 35–243) M. tuberculosis DNA copies were obtained from 74 clinic samplings, compared to a median of 3 (IQR, 1–33; P < .001) obtained from 47 controls. At a threshold of 320 DNA copies, specificity was 100%, and 18% of clinic samples would be classified as positive.Conclusions:This proof-of-concept study suggests that the potential for airborne M. tuberculosis detection based on M. tuberculosis DNA copy yield to enable the identification of high-risk transmission locations. Further optimization of the M. tuberculosis extraction technique and ddPCR data analysis would improve detection and enable robust interpretation of these data.


  • Antiplasmodial and antimycobacterial activities of crude and lead-like enhanced extracts from Namibian medicinal plants

    by Celestine Raidron, Audrey Jordaan, Ronnett Seldon, Digby F. Warner, Carmen de Kock, Dale Taylor, Stefan Louw, Suthananda Sunassee, Renate Hazel Hans


  • Synthesis and comparison of in vitro dual anti-infective activities of novel naphthoquinone hybrids and atovaquone

    by Chané Erasmus, Janine Aucamp, Frans J. Smit, Ronnett Seldon, Audrey Jordaan, Digby F. Warner, David D. N'Da


  • Open Access

    Antimycobacterial Activity, Synergism, and Mechanism of Action Evaluation of Novel Polycyclic Amines against Mycobacterium tuberculosis

    by Erika Kapp, Jacques Joubert, Samantha L. Sampson, Digby F. Warner, Ronnett Seldon, Audrey Jordaan, Margaretha de Vos, Rajan Sharma, Sarel F. Malan

    Mycobacterium tuberculosis has developed extensive resistance to numerous antimycobacterial agents used in the treatment of tuberculosis. Insufficient intracellular accumulation of active moieties allows for selective survival of mycobacteria with drug resistance mutations and accordingly promotes the development of microbial drug resistance. Discovery of compounds with new mechanisms of action and physicochemical properties that promote intracellular accumulation, or compounds that act synergistically with other antimycobacterial drugs, has the potential to reduce and prevent further drug resistance. To this end, antimycobacterial activity, mechanism of action, and synergism in combination therapy were investigated for a series of polycyclic amine derivatives. Compound selection was based on the presence of moieties with possible antimycobacterial activity, the inclusion of bulky lipophilic carriers to promote intracellular accumulation, and previously demonstrated bioactivity that potentially support inhibition of efflux pump activity. The most potent antimycobacterial demonstrated a minimum inhibitory concentration (MIC99) of 9.6μM against Mycobacterium tuberculosis H37Rv. Genotoxicity and inhibition of the cytochrome bc1 respiratory complex were excluded as mechanisms of action for all compounds. Inhibition of cell wall synthesis was identified as a likely mechanism of action for the two most active compounds (14 and 15). Compounds 5 and 6 demonstrated synergistic activity with the known Rv1258c efflux pump substrate, spectinomycin, pointing to possible efflux pump inhibition. For this series, the nature of the side chain, rather than the type of polycyclic carrier, seems to play a determining role in the antimycobacterial activity and cytotoxicity of the compounds. Contrariwise, the nature of the polycyclic carrier, particularly the azapentacycloundecane cage, appears to promote synergistic activity. Results point to the possibility of combining an azapentacycloundecane carrier with a side chain that promotes antimycobacterial activity to develop dual acting molecules for the treatment of Mycobacterium tuberculosis.


  • Synthesis and biological evaluation of bis-N2,N2′-(4-hydroxycoumarin-3-yl)ethylidene]-2,3-dihydroxysuccinodihydrazides

    by Meloddy H. Manyeruke, Thendamudzimu Tshiwawa, Heinrich C. Hoppe, Michelle Isaacs, Ronnett Seldon, Digby F. Warner, Rui W.M. Krause, Perry T. Kaye